Abstract
Engineered organic nanoparticle (ONP)-mediated co-delivery of genes and therapeutic agents is emerging as a powerful tool in the treatment of several genetic and non-genetic disorders. The ONP-based combinatory approach provides a technological platform that delivers genes with chemo/radio/photo/immunotherapies for the prevention or treatment of disease progression.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Chemistry Techniques, Synthetic
-
Combined Modality Therapy
-
Drug Delivery Systems*
-
Drug Therapy
-
Gene Transfer Techniques*
-
Genetic Diseases, Inborn / prevention & control
-
Genetic Diseases, Inborn / therapy
-
Genetic Therapy / methods*
-
Genetic Vectors / chemistry
-
Humans
-
Immunotherapy
-
Liposomes
-
Nanoparticles / chemistry*
-
Neoplasms / prevention & control
-
Neoplasms / therapy
-
Polymers / chemistry
-
Polymers / therapeutic use
-
Radiotherapy